SCHEMBL25906296

SCHEMBL25906296

Cc1ccc(Oc2cccc(C(C)(C)C)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HTT P42858 3/20 0.46
NPC1 O15118 3/20 0.46
ALDH1A1 P00352 3/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 1/20 0.46
ATM Q13315 1/20 0.46
MAP4K4 O95819 1/20 0.44
F2 P00734 2/20 0.41
F10 P00742 2/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41
ST14 Q9Y5Y6 1/20 0.41
MAPT P10636 3/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25946356 0.87 F2 (0.42) MEN1KMT2AHTTNPC1ALDH1A1
SCHEMBL22888699 0.86 MEN1 (0.45) MEN1KMT2AHTTATMF2
SCHEMBL171631 0.86 MEN1 (0.47) MEN1KMT2AHTTNPC1ALDH1A1
SCHEMBL10546373 0.79 MEN1 (0.55) MEN1KMT2AHTTNPC1ALDH1A1
SCHEMBL4371488 0.76 MAP4K4 (0.53) MEN1KMT2AHTTNPC1ALDH1A1
SCHEMBL21330627 0.76 MEN1 (0.52) MEN1KMT2AHTTNPC1ALDH1A1
SCHEMBL10546366 0.76 MEN1 (0.52) MEN1KMT2AHTTNPC1ALDH1A1
SCHEMBL179298 0.75 BTK (0.39) ALDH1A1RAB9AHPGDMAPTNPSR1
SCHEMBL11150846 0.75 ALDH1A1 (0.43) MEN1KMT2AHTTNPC1ALDH1A1
SCHEMBL11153503 0.73 MEN1 (0.43) MEN1KMT2AHTTALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713335-B2 Aminocoumarin compounds and methods of their use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713335-B2 Aminocoumarin compounds and methods of their use AAAS, PROC, AADAC MEN1 3636/4885KMT2A 4274/4885HTT 4796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.